Mother Dairy entered the Mumbai market around four years ago and is now poised to figure among the top three ice cream players this year.

Chennai based public sector lender will raise Rs 1000 crore in tier-- II capital this year to shore its capital base.

Loan growth of SBI was up 21% y-o-y, well aided by healthy growth seen across large corporate, SME & International loan book. Deposits grew 15% y-o-y, CASA ratio decreased 14 bps y-o-y to 46.5% (up 96 bps q-o-q).

Tata Steel’s performance in the fourth quarter suggests that it has become a leaner and meaner company, which has been able to change itself given the persistent tough times, especially in Europe.

Larsen and Toubro's (LT) operating performance for 4QFY13 was meaningfully below our expectations.

As non-farm self-employment increases in rural India, consumer companies continue to register robust sales growth.

State Bank of India (SBI)’s Q4FY2013 performance was below our estimate as its net earnings declined by 18.5% year on year (YoY; 2.9% quarter on quarter [QoQ]) to Rs3,299.2 crore.

Dewan’s recent stock performance appears driven more by perception than facts or fundamentals.

State Bank of India (SBI) is the latest to join the list of companies that have disappointed the Street.

Is there everything wrong with this statement? If you want to create wealth, you need to let your winners run and you have to cut your losers short. Unfortunately this statement is also an "elephant" modern finance is trying to comprehend.

It was heartening to see JSW Steel achieve its steel production and sales forecast of 8.5 million tonnes (mt) and nine mt, respectively, for FY13 despite all odds.

The Apollo Hospitals stock has corrected 11 per cent from its 52-week high of Rs 1,096 on May 17 to Rs 950 currently, after the company reported its fourth quarter and FY13 results, which were slightly below expectations and weak on a sequential basis.

Tata Steel Ltd today shocked its investors with the biggest ever quarterly loss by a private sector company in India. But once you get over the shock, the loss doesn’t bite as the number suggests.

The tussle between the US Food and Drug Administration (US FDA) and Ranbaxy is likely to hit the plans of Indian pharmaceutical companies of making it big in the US generic drugs market.

Sanket Sant, a citizen of India, came to the US at age 21, earning a master's degree in engineering, followed by a doctorate and then landing a well-paying job at a company making semiconductor equipment.

Market Crash image via Shutterstock Global markets, especially in Japan, were spooked today post the US Federal Reserve’s comments on the third round of bond buying programme, commonly known as quantitative easing (QE3).

Daiichi Sankyo, the Japanese parent of Ranbaxy Laboratories, which had bought over the stake of Indian promoters Malvinder and Shivinder Singh, has every right to be irked by the company’s erstwhile promoters and major shareholders of the company

Since the better-than-expected Employment Report for April, published on May 3, market speculation about the Fed tapering off its asset purchase program has increased.

It seems that the finance ministry is working with a single focus of reducing the fiscal deficit, irrespective of the impact it has on individual sectors and companies.

Broadcasting major Zee Entertainment Enterprises reported a higher than expected performance for the quarter ended March 31. Though growth rates moderated on expected lines in the quarter, they were still healthy in the subscription and advertising